Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Distinguished Scientists Lecture Series. New developments in kidney development

M R Hammerman1

  • 1George M. O'Brien Kidney and Urological Disease Center, Renal Division, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA. mhammerm@imgate.wustl.edu

Nephron
|February 6, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term engraftment following transplantation of pig pancreatic primordia into non-immunosuppressed diabetic rhesus macaques.

Xenotransplantation·2007
Same author

Transplantation of metanephroi after preservation in vitro.

American journal of physiology. Regulatory, integrative and comparative physiology·2001
Same author

Transplantation of rat metanephroi into mice.

American journal of physiology. Regulatory, integrative and comparative physiology·2001
Same author

Growing kidneys.

Current opinion in nephrology and hypertension·2001
Same author

Transplantation of metanephroi across the major histocompatibility complex in rats.

American journal of physiology. Regulatory, integrative and comparative physiology·2000
Same author

Inhibition of poly(ADP-ribose) polymerase attenuates ischemic renal injury in rats.

American journal of physiology. Regulatory, integrative and comparative physiology·2000
Same journal

Clinical and Genetic Epidemiology of Autosomal Dominant Polycystic Kidney Disease among patients incident on first kidney replacement therapy between 1990-2023, in a major hospital in the Northwest of Portugal.

Nephron·2026
Same journal

Dietary Potassium and Blood Pressure.

Nephron·2026
Same journal

The Impact of High-Altitude Acclimatization on Frontal Lobe Executive Function: The Mediating Effect of Creatinine.

Nephron·2026
Same journal

Expert Commentary of the Recent International Pediatric Nephrology Association IgA Vasculitis Nephritis Guidelines.

Nephron·2026
Same journal

Acute effects of exercise on the nephron index under different conditions in middle-aged males - a preliminary study.

Nephron·2026
Same journal

Lysozyme-Associated Nephropathy in Myeloid Neoplasms: A Clinicopathological and Mass Spectrometric Study of Two Cases.

Nephron·2026
See all related articles

Transplanting embryonic kidneys (metanephroi) into rats showed reduced immune rejection compared to adult kidneys. This suggests metanephroi could be a viable alternative for treating kidney failure.

Area of Science:

  • Nephrology
  • Transplantation immunology
  • Developmental biology

Background:

  • Kidney transplantation is limited by donor organ availability.
  • Renal xenografts are a potential solution but face immune rejection challenges.
  • Embryonic kidneys (metanephroi) may elicit a reduced host immune response compared to adult kidneys.

Discussion:

  • Transplanted metanephroi integrate as chimeric organs, utilizing the host's vasculature.
  • This integration occurs without the need for immunosuppression in rat models.
  • Adult kidney grafts, conversely, experience rapid rejection within seven days.

Key Insights:

  • Metanephric tissue demonstrates lower immunogenicity than developed adult kidney tissue.
  • Successful vascularization, growth, and function of transplanted metanephroi were observed.

Related Experiment Videos

  • Metanephroi transplantation bypasses the typical rejection pathways seen with adult organs.

    • Outlook:

    • Metanephroi transplantation offers a novel therapeutic strategy for chronic renal failure.
    • Further research into metanephric tissue immunomodulation could advance xenotransplantation.
    • This approach may reduce reliance on immunosuppressive drugs in kidney replacement therapy.